Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (316K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (83)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Shafer, R. W.
Right arrow Articles by Chan, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shafer, R. W.
Right arrow Articles by Chan, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 27, Issue 1 348-352, Copyright © 1999 by Oxford University Press

ARTICLES

Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database

RW Shafer, D Stevenson and B Chan
Division of Infectious Diseases, Stanford University Medical Center, Stanford, CA 94305, USA. rshafer@cmgm.stanford.edu

The HIV RT and Protease Sequence Database is an on-line relational database that catalogues evolutionary and drug-related human immunodeficiency virus reverse transcriptase (RT) and protease sequence variation (http://hivdb.stanford.edu). The database contains a compilation of nearly all published HIV RT and protease sequences including International Collaboration database submissions (e.g., GenBank) and sequences published in journal articles. Sequences are linked to data about the source of the sequence sample and the anti-HIV drug treatment history of the individual from whom the isolate was obtained. The database is curated and sequences are annotated with data from 180 literature references. Users can retrieve additional data and view alignments of sequences sets meeting specific criteria (e.g., treatment history, subtype, presence of a particular mutation).
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Virol.Home page
J. D. Baxter, J. M. Schapiro, C. A. B. Boucher, V. M. Kohlbrenner, D. B. Hall, J. R. Scherer, and D. L. Mayers
Genotypic Changes in Human Immunodeficiency Virus Type 1 Protease Associated with Reduced Susceptibility and Virologic Response to the Protease Inhibitor Tipranavir
J. Virol., November 1, 2006; 80(21): 10794 - 10801.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. E. Foulkes, M. Prabu-Jeyabalan, D. Cooper, G. J. Henderson, J. Harris, R. Swanstrom, and C. A. Schiffer
Role of Invariant Thr80 in Human Immunodeficiency Virus Type 1 Protease Structure, Function, and Viral Infectivity
J. Virol., July 15, 2006; 80(14): 6906 - 6916.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. Prabu-Jeyabalan, N. M. King, E. A. Nalivaika, G. Heilek-Snyder, N. Cammack, and C. A. Schiffer
Substrate Envelope and Drug Resistance: Crystal Structure of RO1 in Complex with Wild-Type Human Immunodeficiency Virus Type 1 Protease.
Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1518 - 1521.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Prabu-Jeyabalan, E. A. Nalivaika, K. Romano, and C. A. Schiffer
Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate.
J. Virol., April 1, 2006; 80(7): 3607 - 3616.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
T. de Oliveira, K. Deforche, S. Cassol, M. Salminen, D. Paraskevis, C. Seebregts, J. Snoeck, E. J. van Rensburg, A. M. J. Wensing, D. A. van de Vijver, et al.
An automated genotyping system for analysis of HIV-1 and other microbial sequences
Bioinformatics, October 1, 2005; 21(19): 3797 - 3800.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
C. Y. W. Tong, J. Mullen, R. Kulasegaram, A. De Ruiter, S. O'Shea, and I. L. Chrystie
Genotyping of B and Non-B Subtypes of Human Immunodeficiency Virus Type 1
J. Clin. Microbiol., September 1, 2005; 43(9): 4623 - 4627.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
W. Resch, N. Parkin, T. Watkins, J. Harris, and R. Swanstrom
Evolution of Human Immunodeficiency Virus Type 1 Protease Genotypes and Phenotypes In Vivo under Selective Pressure of the Protease Inhibitor Ritonavir
J. Virol., August 15, 2005; 79(16): 10638 - 10649.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Prabu-Jeyabalan, E. A. Nalivaika, N. M. King, and C. A. Schiffer
Structural Basis for Coevolution of a Human Immunodeficiency Virus Type 1 Nucleocapsid-p1 Cleavage Site with a V82A Drug-Resistant Mutation in Viral Protease
J. Virol., November 15, 2004; 78(22): 12446 - 12454.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
N. M. King, M. Prabu-Jeyabalan, E. A. Nalivaika, P. Wigerinck, M.-P. de Bethune, and C. A. Schiffer
Structural and Thermodynamic Basis for the Binding of TMC114, a Next-Generation Human Immunodeficiency Virus Type 1 Protease Inhibitor
J. Virol., November 1, 2004; 78(21): 12012 - 12021.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
K. Wang, R. Samudrala, J. Mittler, S. Qari, W. Heneine, N. Hellmann, and L. Bacheler
Weak Agreement between Antivirogram and PhenoSense Assays in Predicting Reduced Susceptibility to Antiretroviral Drugs
J. Clin. Microbiol., May 1, 2004; 42(5): 2353 - 2354.
[Full Text] [PDF]

Home page
 J. Virol.Home page
B. C. Logsdon, J. F. Vickrey, P. Martin, G. Proteasa, J. I. Koepke, S. R. Terlecky, Z. Wawrzak, M. A. Winters, T. C. Merigan, and L. C. Kovari
Crystal Structures of a Multidrug-Resistant Human Immunodeficiency Virus Type 1 Protease Reveal an Expanded Active-Site Cavity
J. Virol., March 15, 2004; 78(6): 3123 - 3132.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. A. Collins, M. G. Thompson, E. Paintsil, M. Ricketts, J. Gedzior, and L. Alexander
Competitive Fitness of Nevirapine-Resistant Human Immunodeficiency Virus Type 1 Mutants
J. Virol., January 15, 2004; 78(2): 603 - 611.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
E. Nicastri, L. Sarmati, G. d'Ettorre, S. G. Parisi, L. Palmisano, C. Galluzzo, M. Montano, I. Uccella, R. Amici, F. Gatti, et al.
High Prevalence of M184 Mutation among Patients with Viroimmunologic Discordant Responses to Highly Active Antiretroviral Therapy and Outcomes after Change of Therapy Guided by Genotypic Analysis
J. Clin. Microbiol., July 1, 2003; 41(7): 3007 - 3012.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
B. J. Betts and R. W. Shafer
Algorithm Specification Interface for Human Immunodefiency Virus Type 1 Genotypic Interpretation
J. Clin. Microbiol., June 1, 2003; 41(6): 2792 - 2794.
[Full Text] [PDF]

Home page
 J. Virol.Home page
T. D. Wu, C. A. Schiffer, M. J. Gonzales, J. Taylor, R. Kantor, S. Chou, D. Israelski, A. R. Zolopa, W. J. Fessel, and R. W. Shafer
Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease following Different Protease Inhibitor Treatments
J. Virol., April 15, 2003; 77(8): 4836 - 4847.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Prabu-Jeyabalan, E. A. Nalivaika, N. M. King, and C. A. Schiffer
Viability of a Drug-Resistant Human Immunodeficiency Virus Type 1 Protease Variant: Structural Insights for Better Antiviral Therapy
J. Virol., December 20, 2002; 77(2): 1306 - 1315.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
J. Aslanzadeh
HIV Resistance Testing: an Update
Ann. Clin. Lab. Sci., October 1, 2002; 32(4): 406 - 413.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
R. W. Shafer
Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance
Clin. Microbiol. Rev., April 1, 2002; 15(2): 247 - 277.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
K. Yusa, W. Song, M. Bartelmann, and S. Harada
Construction of a Human Immunodeficiency Virus Type 1 (HIV-1) Library Containing Random Combinations of Amino Acid Substitutions in the HIV-1 Protease due to Resistance by Protease Inhibitors
J. Virol., February 22, 2002; 76(6): 3031 - 3037.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
E.-Y. Kim, M. A. Winters, R. M. Kagan, and T. C. Merigan
Functional Correlates of Insertion Mutations in the Protease Gene of Human Immunodeficiency Virus Type 1 Isolates from Patients
J. Virol., November 15, 2001; 75(22): 11227 - 11233.
[Abstract] [Full Text] [PDF]

Home page
 AIDS Clin CareHome page
HIV Drug Resistance Testing: An Update for the Clinician
AIDS Clinical Care, October 1, 2001; 2001(1001): 8 - 8.
[Full Text]

Home page
 J. Virol.Home page
L. Doukhan and E. Delwart
Population Genetic Analysis of the Protease Locus of Human Immunodeficiency Virus Type 1 Quasispecies Undergoing Drug Selection, Using a Denaturing Gradient-Heteroduplex Tracking Assay
J. Virol., July 15, 2001; 75(14): 6729 - 6736.
[Abstract] [Full Text]

Home page
 J. Clin. Microbiol.Home page
P. A. Cane, A. de Ruiter, P. Rice, M. Wiselka, R. Fox, and D. Pillay
Resistance-Associated Mutations in the Human Immunodeficiency Virus Type 1 Subtype C Protease Gene from Treated and Untreated Patients in the United Kingdom
J. Clin. Microbiol., July 1, 2001; 39(7): 2652 - 2654.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
H. C. F. Côté, Z. L. Brumme, and P. R. Harrigan
Human Immunodeficiency Virus Type 1 Protease Cleavage Site Mutations Associated with Protease Inhibitor Cross-Resistance Selected by Indinavir, Ritonavir, and/or Saquinavir
J. Virol., January 15, 2001; 75(2): 589 - 594.
[Abstract] [Full Text]

Home page
 Nucleic Acids ResHome page
R. Kantor, R. Machekano, M. J. Gonzales, K. Dupnik, J. M. Schapiro, and R. W. Shafer
Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs
Nucleic Acids Res., January 1, 2001; 29(1): 296 - 299.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
L. Vergne, M. Peeters, E. Mpoudi-Ngole, A. Bourgeois, F. Liegeois, C. Toure-Kane, S. Mboup, C. Mulanga-Kabeya, E. Saman, J. Jourdan, et al.
Genetic Diversity of Protease and Reverse Transcriptase Sequences in Non-Subtype-B Human Immunodeficiency Virus Type 1 Strains: Evidence of Many Minor Drug Resistance Mutations in Treatment-Naive Patients
J. Clin. Microbiol., November 1, 2000; 38(11): 3919 - 3925.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Martinez-Picado, M. P. DePasquale, N. Kartsonis, G. J. Hanna, J. Wong, D. Finzi, E. Rosenberg, H. F. Gunthard, L. Sutton, A. Savara, et al.
Antiretroviral resistance during successful therapy of HIV type 1 infection
PNAS, September 26, 2000; 97(20): 10948 - 10953.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
N. Yahi, C. Tamalet, C. Tourrès, N. Tivoli, F. Ariasi, F. Volot, J.-A. Gastaut, H. Gallais, J. Moreau, and J. Fantini
Mutation Patterns of the Reverse Transcriptase and Protease Genes in Human Immunodeficiency Virus Type 1-Infected Patients Undergoing Combination Therapy: Survey of 787 Sequences
J. Clin. Microbiol., December 1, 1999; 37(12): 4099 - 4106.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
R. W. Shafer, P. Hsu, A. K. Patick, C. Craig, and V. Brendel
Identification of Biased Amino Acid Substitution Patterns in Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Protease Inhibitors
J. Virol., July 1, 1999; 73(7): 6197 - 6202.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.